{"id":"W2587772896","doi":"10.1182/blood.v104.11.608.608","title":"Phase II Trial of Bortezomib in Mantle Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Bortezomib; Mantle cell lymphoma; Nausea; Internal medicine; Surgery; Neutropenia; Adverse effect; Chills; Vomiting; Progressive disease; Phases of clinical research; Gastroenterology; Chemotherapy; Multiple myeloma; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002255024,0.001653186,0.001473433,0.0005115769,0.0005399351,0.001043847,0.0008507107,0.001486477,0.006427667],"category_scores_gemma":[0.0007611242,0.0005664026,0.0008779111,0.000370698,0.0008167665,0.0006488223,0.0004572591,0.003506181,0.001599949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006096378,"about_ca_system_score_gemma":0.001069764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004989507,"about_ca_topic_score_gemma":0.0009745,"domain_scores_codex":[0.9994553,0.0003011894,0.00002812615,0.00005907936,0.00004403606,0.0001122465],"domain_scores_gemma":[0.9993799,0.0001147409,0.00009221541,0.00005375734,0.00002979591,0.0003296103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7243119,0.06562829,0.005780397,0.001528839,0.0008908639,0.0006709085,0.0003083671,0.001833009,0.04652547,0.0007332289,0.01165431,0.1401344],"study_design_scores_gemma":[0.7867158,0.1971626,0.00517437,0.00005059364,0.0002018195,0.0002879814,0.00003648658,0.0006787338,0.003303599,0.0002235863,0.006149523,0.0000148674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628562,0.01330411,0.00135298,0.002539737,0.0007574214,0.008175133,0.003059531,0.0003170078,0.007637935],"genre_scores_gemma":[0.9694353,0.003850724,0.002474856,0.002949535,0.000596459,0.005616699,0.005918566,0.00005607086,0.0091018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006427667,"threshold_uncertainty_score":0.02150273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01379135711897934,"score_gpt":0.2736314929560739,"score_spread":0.2598401358370946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}